Summit Therapeutics (SMMT) logo

SMMT earnings date, and what happened the last 4 times

Next report

Tue Oct 27

Quality Score today -1

After the close, today. Expected: the company has not confirmed it.

SMMT closed higher after 1 of its last 4 reports. On average it closed -11.7% the session after a report.

The moment SMMT reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when SMMT reports, with its figures

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

What happened after SMMT's last 4 reports

SMMT's last 4 earnings reports
ReportedScore
going in
GapReaction
Jul 23, 20262026 · After close0estimated-8.4%-8.8%
Apr 30, 20262026 · After close4estimated-25.4%-24.9%
Feb 23, 20262026 · After close1estimated-1.9%+0.2%
Jan 12, 20262026 · Before open3estimated+0.9%-13.4%
  • Jul 23, 2026, after the close: the next session SMMT opened -8.4% and closed -8.8%, and five sessions on it stood -10.3%. Its Quality Score going in was 0 (Below Average), estimated.
  • Apr 30, 2026, after the close: the next session SMMT opened -25.4% and closed -24.9%, and five sessions on it stood -20.1%. Its Quality Score going in was 4 (Below Average), estimated.
  • Feb 23, 2026, after the close: the next session SMMT opened -1.9% and closed +0.2%, and five sessions on it stood +0.6%. Its Quality Score going in was 1 (Below Average), estimated.
  • Jan 12, 2026, before the open: that session SMMT opened +0.9% and closed -13.4%, and five sessions on it stood -13.4%. Its Quality Score going in was 3 (Below Average), estimated.

Across these 4 reports SMMT opened higher after 1 of 4 and closed higher after 1 of 4; on average it opened -8.7%, closed -11.7%, and stood -10.8% five sessions on. Its Quality Score is -1 today, against 0 going into its Jul 23, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: -24.9% after the Apr 30, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see SMMT's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about SMMT's earnings

As of Oct 27, 2026: Summit Therapeutics (SMMT): expected to report Tue Oct 27, after the close. SMMT closed higher after 1 of its last 4 reports. Its Quality Score is -1 (Poor). Scores as of 12:12 AM ET, 15 minutes behind.

When is SMMT's next earnings date?

Expected to report Tue Oct 27, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. SMMT closed higher after 1 of its last 4 reports. Past behavior, not a forecast.

Does SMMT report before or after the market?

SMMT is expected to report Tue Oct 27, after the close. Its last 4 reports came 3 after the close and 1 before the open.

How did SMMT stock react to its last earnings report?

Jul 23, 2026, after the close: the next session SMMT opened -8.4% and closed -8.8%, and five sessions on it stood -10.3%.

Does SMMT stock usually go up after earnings?

SMMT closed higher after 1 of its last 4 reports. On average it closed -11.7% the session after a report, after opening -8.7%. Past behavior, not a forecast.

Summit Therapeutics' page has its Quality Score, its chart, and its insiders' trades. Everyone reporting beside it: this week's earnings.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.